{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:18:58Z","timestamp":1790533138217,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1124\/jpet.117.246751","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T17:30:47Z","timestamp":1524072647000},"page":"711-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Drug-Induced Alterations of Mitochondrial DNA Homeostasis in Steatotic and Nonsteatotic HepaRG Cells"],"prefix":"10.1016","volume":"365","author":[{"given":"Dounia","family":"Le Guillou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Begriche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Ho\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lomb\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Labbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Fromenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.117.246751_bib1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bbadis.2012.07.002","article-title":"Defective mitochondrial fusion, altered respiratory function, and distorted cristae structure in skin fibroblasts with heterozygous OPA1 mutations","volume":"1822","author":"Agier","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.117.246751_bib2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.tiv.2012.05.008","article-title":"Optimization of the HepaRG cell model for drug metabolism and toxicity studies","volume":"26","author":"Anth\u00e9rieu","year":"2012","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/jpet.117.246751_bib3","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep.24290","article-title":"Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells","volume":"53","author":"Anth\u00e9rieu","year":"2011","journal-title":"Hepatology"},{"key":"10.1124\/jpet.117.246751_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role","volume":"35","author":"Aubert","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1124\/jpet.117.246751_bib6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"10.1124\/jpet.117.246751_bib7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.117.246751_bib8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bbagen.2013.10.012","article-title":"Can we optimise the exercise training prescription to maximise improvements in mitochondria function and content?","volume":"1840","author":"Bishop","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.117.246751_bib9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/tox.22301","article-title":"Bisphenol a induces steatosis in HepaRG cells using a model of perinatal exposure","volume":"32","author":"Bucher","year":"2017","journal-title":"Environ Toxicol"},{"key":"10.1124\/jpet.117.246751_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ddrr.106","article-title":"Pharmacologic effects on mitochondrial function","volume":"16","author":"Cohen","year":"2010","journal-title":"Dev Disabil Res Rev"},{"key":"10.1124\/jpet.117.246751_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s13181-010-0047-0","article-title":"Severe drug-induced liver injury associated with prolonged use of linezolid","volume":"6","author":"De Bus","year":"2010","journal-title":"J Med Toxicol"},{"key":"10.1124\/jpet.117.246751_bib12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/hep.1840190422","article-title":"Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions","volume":"19","author":"Deschamps","year":"1994","journal-title":"Hepatology"},{"key":"10.1124\/jpet.117.246751_bib13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1124\/jpet.117.246751_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/toxsci\/kfn056","article-title":"In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone","volume":"103","author":"Dykens","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.117.246751_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tiv.2016.03.016","article-title":"A combined in vitro approach to improve the prediction of mitochondrial toxicants","volume":"34","author":"Eakins","year":"2016","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/jpet.117.246751_bib16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jhep.2012.12.018","article-title":"Drug-induced liver injury in obesity","volume":"58","author":"Fromenty","year":"2013","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.117.246751_bib17","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0022-3565(25)22965-2","article-title":"Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II","volume":"255","author":"Fromenty","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.246751_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.21687","article-title":"Effects of rosiglitazone on the liver histology and mitochondrial function in ob\/ob mice","volume":"46","author":"Garc\u00eda-Ruiz","year":"2007","journal-title":"Hepatology"},{"key":"10.1124\/jpet.117.246751_bib19","doi-asserted-by":"crossref","first-page":"e00542-17","DOI":"10.1128\/AAC.00542-17","article-title":"Influence of mitochondrial genetics on the mitochondrial toxicity of linezolid in blood cells and skin nerve fibers","volume":"61","author":"Garrabou","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.117.246751_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nmd.2007.12.008","article-title":"Modulation of mitochondrial morphology by bioenergetics defects in primary human fibroblasts","volume":"18","author":"Guillery","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1124\/jpet.117.246751_bib21","doi-asserted-by":"crossref","first-page":"20888","DOI":"10.1073\/pnas.0811258106","article-title":"Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity","volume":"105","author":"Hobbie","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.117.246751_bib22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jcp.21353","article-title":"Oxidative stress induces GLUT4 translocation by activation of PI3-K\/Akt and dual AMPK kinase in cardiac myocytes","volume":"215","author":"Horie","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1124\/jpet.117.246751_bib23","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1124\/dmd.110.037077","article-title":"Development of a highly sensitive cytotoxicity assay system for CYP3A4-mediated metabolic activation","volume":"39","author":"Hosomi","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.117.246751_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/07853890.2011.572905","article-title":"Ritonavir-boosted protease inhibitors in HIV therapy","volume":"43","author":"Hull","year":"2011","journal-title":"Ann Med"},{"key":"10.1124\/jpet.117.246751_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/187152106777697871","article-title":"Mitochondrial, metabolic and genotoxic effects of antiretroviral nucleoside reverse-transcriptase inhibitors","volume":"5","author":"Igoudjil","year":"2006","journal-title":"Antiinfect Agents Med Chem"},{"key":"10.1124\/jpet.117.246751_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/14740338.2.6.581","article-title":"Hepatotoxicity of thiazolidinediones","volume":"2","author":"Isley","year":"2003","journal-title":"Expert Opin Drug Saf"},{"key":"10.1124\/jpet.117.246751_bib27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.tiv.2015.02.011","article-title":"The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death","volume":"29","author":"Kamalian","year":"2015","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/jpet.117.246751_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3565(25)12840-1","article-title":"Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes","volume":"277","author":"Kumar","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.246751_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1472-8206.2008.00608.x","article-title":"Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies","volume":"22","author":"Labbe","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/jpet.117.246751_bib30","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1021\/tx2004147","article-title":"Metabolomic screening and identification of the bioactivation pathways of ritonavir","volume":"24","author":"Li","year":"2011","journal-title":"Chem Res Toxicol"},{"issue":"Suppl 2","key":"10.1124\/jpet.117.246751_bib31","first-page":"ii17","article-title":"Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with gram-positive infections","volume":"51","author":"MacGowan","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/jpet.117.246751_bib32","doi-asserted-by":"crossref","first-page":"25.4.1","DOI":"10.1002\/0471140856.tx2504s60","article-title":"Identifying compounds that induce opening of the mitochondrial permeability transition pore in isolated rat liver mitochondria","volume":"60","author":"Marroquin","year":"2014","journal-title":"Curr Protoc Toxicol"},{"key":"10.1124\/jpet.117.246751_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants","volume":"97","author":"Marroquin","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.117.246751_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1023\/A:1016009029536","article-title":"The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients","volume":"13","author":"Massarella","year":"1996","journal-title":"Pharm Res"},{"issue":"Suppl 1","key":"10.1124\/jpet.117.246751_bib35","first-page":"212","article-title":"Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity","volume":"3","author":"Massart","year":"2017","journal-title":"J Clin Transl Res"},{"key":"10.1124\/jpet.117.246751_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2133\/dmpk.21.347","article-title":"Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review","volume":"21","author":"Masubuchi","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.117.246751_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2015.12.020","article-title":"A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: application to acetaminophen","volume":"292","author":"Michaut","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.117.246751_bib38","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1111\/liv.12514","article-title":"Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease","volume":"34","author":"Michaut","year":"2014","journal-title":"Liver Int"},{"key":"10.1124\/jpet.117.246751_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.freeradbiomed.2016.01.012","article-title":"AMPK signaling in skeletal muscle during exercise: role of reactive oxygen and nitrogen species","volume":"98","author":"Morales-Alamo","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/jpet.117.246751_bib40","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.celrep.2015.02.034","article-title":"Tetracyclines disturb mitochondrial function across eukaryotic models: a call for caution in biomedical research","volume":"10","author":"Moullan","year":"2015","journal-title":"Cell Reports"},{"key":"10.1124\/jpet.117.246751_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.taap.2007.06.003","article-title":"Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration","volume":"223","author":"Nadanaciva","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.117.246751_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fphar.2017.00367","article-title":"Hepatocellular toxicity associated with tyrosine kinase inhibitors: mitochondrial damage and inhibition of glycolysis","volume":"8","author":"Paech","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.117.246751_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbabio.2016.01.002","article-title":"Reduced cardiolipin content decreases respiratory chain capacities and increases ATP synthesis yield in the human HepaRG cells","volume":"1857","author":"Peyta","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.117.246751_bib44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/febs.13820","article-title":"Mitochondrial biogenesis and clearance: a balancing act","volume":"284","author":"Ploumi","year":"2017","journal-title":"FEBS J"},{"key":"10.1124\/jpet.117.246751_bib45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/toxsci\/KFS197","article-title":"Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria","volume":"129","author":"Porceddu","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.117.246751_bib46","series-title":"Drug-Induced Liver Toxicity","first-page":"283","article-title":"In vitro assessment of mitochondrial toxicity to predict drug-induced liver injury","author":"Porceddu","year":"2018"},{"key":"10.1124\/jpet.117.246751_bib47","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1083\/jcb.201702058","article-title":"Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals","volume":"216","author":"Quir\u00f3s","year":"2017","journal-title":"J Cell Biol"},{"key":"10.1124\/jpet.117.246751_bib48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1042\/bj20021594","article-title":"Mitochondrial threshold effects","volume":"370","author":"Rossignol","year":"2003","journal-title":"Biochem J"},{"key":"10.1124\/jpet.117.246751_bib49","doi-asserted-by":"crossref","first-page":"33426","DOI":"10.1074\/jbc.274.47.33426","article-title":"Threshold effect and tissue specificity. Implication for mitochondrial cytopathies","volume":"274","author":"Rossignol","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.246751_bib50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tem.2012.06.006","article-title":"Transcriptional integration of mitochondrial biogenesis","volume":"23","author":"Scarpulla","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/jpet.117.246751_bib51","series-title":"Mitochondria in Liver Disease","first-page":"283","article-title":"Mitochondria in liver disease","author":"Schon","year":"2015"},{"key":"10.1124\/jpet.117.246751_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(01)00311-7","article-title":"Antiretroviral drug toxicity\u2014a challenge for the hepatologist?","volume":"36","author":"Spengler","year":"2002","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.117.246751_bib53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies","volume":"28","author":"Sunny","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/jpet.117.246751_bib54","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/CIRCRESAHA.116.305420","article-title":"Maintaining ancient organelles: mitochondrial biogenesis and maturation","volume":"116","author":"Vega","year":"2015","journal-title":"Circ Res"},{"key":"10.1124\/jpet.117.246751_bib55","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/febs.13175","article-title":"New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond","volume":"282","author":"Villena","year":"2015","journal-title":"FEBS J"},{"key":"10.1124\/jpet.117.246751_bib56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.20074","article-title":"Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine","volume":"39","author":"Walker","year":"2004","journal-title":"Hepatology"},{"key":"10.1124\/jpet.117.246751_bib57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.4.110807.092314","article-title":"Mitochondrial energetics and therapeutics","volume":"5","author":"Wallace","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1124\/jpet.117.246751_bib58","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1517\/17425255.2014.939628","article-title":"Mitochondrial toxicity assessment in industry\u2014a decade of technology development and insight","volume":"10","author":"Will","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.117.246751_bib59","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/dmd.115.065979","article-title":"CYP3A activity and expression in nonalcoholic fatty liver disease","volume":"43","author":"Woolsey","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.117.246751_bib60","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-3-642-00663-0_14","article-title":"Troglitazone","volume":"196","author":"Yokoi","year":"2010","journal-title":"Handb Exp Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524268051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524268051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.117.246751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:05:42Z","timestamp":1739995542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524268051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0022356524268051"],"URL":"https:\/\/doi.org\/10.1124\/jpet.117.246751","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Induced Alterations of Mitochondrial DNA Homeostasis in Steatotic and Nonsteatotic HepaRG Cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.117.246751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}